Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland

NCT00980213 · clinicaltrials.gov ↗

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms
Renal Cell Carcinoma

Interventions

DRUG: sunitinib

Sponsor

Pirkko-Liisa Kellokumpu-Lehtinen

Collaborators

[object Object]
[object Object]